Glucocorticoid use in patients with adrenal insufficiency following administration of the COVID-19 vaccine: a pituitary society statement Laurence KatznelsonMônica Gadelha OriginalPaper 10 February 2021 Pages: 143 - 145
HOMA-IR in acromegaly: a systematic review and meta-analysis Betina BiagettiAnna AulinasRafael Simó OriginalPaper 21 October 2020 Pages: 146 - 158
Establishing a papillary craniopharyngioma cell line by SV40LT-mediated immortalization Yi LiuChao-hu WangSong-tao Qi OriginalPaper 12 October 2020 Pages: 159 - 169
Prognostic value of nadir GH levels for long-term biochemical remission or recurrence in surgically treated acromegaly Pamela U. FredaJeffrey N. BruceKalmon D. Post OriginalPaper 30 October 2020 Pages: 170 - 183
The effect of somatostatin analogs and acromegaly on the upper gastrointestinal system Serdar SahinTevhide Betul IcliPinar Kadioglu OriginalPaper 19 October 2020 Pages: 184 - 191
Clinical, biological, radiological, and pathological comparison of sparsely and densely granulated somatotroph adenomas: a single center experience from a cohort of 131 patients with acromegaly Amy A. SwansonDana EricksonCaterina Giannini OriginalPaper 19 October 2020 Pages: 192 - 206
Corticotroph tumor progression during long-term therapy with osilodrostat in a patient with persistent Cushing’s disease Cédric Fontaine-SylvestreLaurent Létourneau-GuillonAndré Lacroix OriginalPaper 19 October 2020 Pages: 207 - 215
Vasculometabolic effects in patients with congenital growth hormone deficiency with and without GH replacement therapy during adulthood Isabela Peixoto BiscottoValéria Aparecida Costa HongLuciani Renata Silveira Carvalho OriginalPaper 24 October 2020 Pages: 216 - 228
Congenital hypopituitarism in two brothers with a duplication of the ‘acrogigantism gene’ GPR101: clinical findings and review of the literature Melitza S. M. ElizabethAnnemieke J. M. H. VerkerkLaura C. G. de Graaff OriginalPaper Open access 13 November 2020 Pages: 229 - 241
Biliary adverse events in acromegaly during somatostatin receptor ligands: predictors of onset and response to ursodeoxycholic acid treatment N. PrencipeC. BonaS. Grottoli OriginalPaper Open access 09 November 2020 Pages: 242 - 251
Genetics, clinical features and outcomes of non-syndromic pituitary gigantism: experience of a single center from Sao Paulo, Brazil Ericka B. TrarbachGiampaolo TrivellinRaquel S. Jallad OriginalPaper 06 November 2020 Pages: 252 - 261
The direct and indirect impact of the COVID-19 pandemic on the care of patients with pituitary disease: a cross sectional study Anneke GrafHani J. MarcusStephanie E. Baldeweg OriginalPaper Open access 24 November 2020 Pages: 262 - 268
Management of sellar and parasellar tumors becoming symptomatic during pregnancy: a practical algorithm based on multi-center experience and systematic literature review Matteo ZoliFederica GuaraldiDiego Mazzatenta OriginalPaper Open access 17 November 2020 Pages: 269 - 283
Postoperative diabetes insipidus: how to define and grade this complication? Friso de VriesDaniel J. LobattoNienke R. Biermasz ReviewPaper Open access 29 September 2020 Pages: 284 - 291
Chiasmapexy for secondary empty sella syndrome: diagnostic and therapeutic considerations Thomas GraillonThibault PasseriSébastien Froelich ReviewPaper 02 November 2020 Pages: 292 - 301